Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 232
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #225: Q1 Lobbying Update; Individual vs. Group MDMA Therapy Study Launches; Australia Loosens Psychedelics Access Regulations; VA Launches “New” MDMA Trial
Three Brain Injuries, One Iboga Protocol, and What It Tells Us
The War on Drugs Was Never About Drugs. Psychedelic Healing Must Reckon With That.
A Dispatch from APA’s Annual Meeting: Psychedelics Return at an Awkward Moment for American Psychiatry
Momentum Amidst Tumult: The FDA Reshuffle, Approval Timelines, and the Compass-Usona Race
Psyence Group and Pure Extracts Finalize “Pure Psyence,” A Joint Venture...
PharmaTher Announces Closing of CAD$10 Million Private Placement with Institutional Investors
PharmaTher Retains Former FDA Psychiatry Division Director Dr. Thomas Laughren as...
Mindset Pharma Expands Pipeline: Identifies Additional Next Generation 5-MeO-DMT-Inspired Lead Candidates
Red Light Holland: Initial Results From Red Light Oregon Market Research...
Psychedelics and Pregnancy: A Look Into the Safety, Research and Legality
MindMed Appoints University of North Carolina Psychiatrist and Pharmacologist Dr. Bryan...
MDMA: A Catalyst for ED-PTSD Treatment
PT264 – Gibrán Rivera – Group Process, Self-sovereignty, and Rethinking Masculinity
Psychedelic Research Bulletin: July & August 2021
Load more